TrialAnnals of surgical oncology2013

Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma.

Marjun P Duldulao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.